http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
xiii, 345 pages : illustrations (some color) ; 27 cm.
Short communication A : Early determinants of metastatic potential -- Short communication B : Update in prostate cancer pathogenesis -- Molecular determinants of neuroplasticity in affective disorders : the study of protein kinases in human brain and in cell culture -- Oncogene proteins : targets for cancer immuno-cell therapy -- PI3K/Akt/mTOR signaling pathway : implications for human cancer -- Modulation of tumor angiogenesis by polyunsaturated fatty acids : what is the mechanism? -- Survivin splice variants : new players in cancer -- Toy story : small-molecule inhibitors and small peptides of Bcl-2 family proteins -- New aspects of AKT signaling : nucleus, calcium, and hormone -- Non-receptor protein tyrosine kinase fes as a candidate for anticancer molecular targeting therapy -- Molecular and cellular alterations produced by HER2 overexpression and modified by HER2 inhibition in cancer cells -- Aurora kinases as therapeutic targets of antioncogenic drugs -- Diabetes increases risk for oral carcinogenesis by induction of cell proliferation and reduction of cell adhesion : an animal model study -- Apoptotic cell death inhibitors : implications of clusterin and BCL-2 in carcinogenesis and treatment -- Proteomics, bioinformatics and advanced biotechnology for oncogene protein research.
Peter B. Murphy and Jason R. Clarke, editors.
Includes bibliographical references and index.